Fig 1.
Cohorts for comparing the impact of PCV10 in vaccine-eligible children.
Fig 2.
Cohorts for comparing the indirect effect of PCV10 in unvaccinated children.
Table 1.
ICD-10 codes compatible with pneumonia and their distribution in the two reference cohorts from 2003 to 2006 and 2005 to 2008.
Fig 3.
Monthly incidence rates of pneumonia in children <24 months of age from 2000 through end 2014 with vertical lines showing calendar years and dashed vertical lines showing epidemiological years.
Fig 4.
Annual pneumonia rates in children less than 2 years of age by epidemic years.
A) all pneumonia outcomes, HDP hospital-diagnosed pneumonia, HTPP hospital-treated primary pneumonia, HDPP hospital-diagnosed pneumococcal pneumonia and empyema; B) HDPP and empyema on different scale.
Fig 5.
Annual pneumonia rates in children 2 to 4 years of age by epidemic years.
A) all pneumonia outcomes, HDP hospital-diagnosed pneumonia, HTPP hospital-treated primary pneumonia, HDPP hospital-diagnosed pneumococcal pneumonia and empyema; B) HDPP and empyema on different scale.
Table 2.
Rates of pneumonia and the corresponding rate reductions in PCV10 eligible target cohort vs. reference cohorts.
Fig 6.
The incidence of hospital-treated primary pneumonia (HTPP) by age in vaccine-eligible target cohort compared to reference cohorts before introduction.
Table 3.
Rates of pneumonia and the corresponding rate reductions in unvaccinated study cohort vs. reference cohorts.